Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies.
Mir Sohail FazeliVadim KhaychukKeith WittstockBoris BreznenGrace CrocketMir-Masoud PourrahmatLeticia FerriPublished in: Clinical medicine insights. Arthritis and musculoskeletal disorders (2021)
Autoantibodies appear to increase CVD risk; however, the magnitude of the increase and the types of CVD outcomes affected are still unclear. Prospective studies with larger populations are required to further understand and quantify the association, including the causal pathway, between specific risk factors and CVD outcomes in RA patients.
Keyphrases
- rheumatoid arthritis
- risk factors
- cardiovascular disease
- end stage renal disease
- systemic lupus erythematosus
- disease activity
- chronic kidney disease
- type diabetes
- peritoneal dialysis
- prognostic factors
- ankylosing spondylitis
- interstitial lung disease
- patient reported outcomes
- metabolic syndrome
- coronary artery disease
- skeletal muscle
- glycemic control
- weight loss
- genetic diversity